Noticias del mercado de valores

Últimas noticias financieras · Actualizado May 23, 2026

CEG
▬ mixed

Por qué Constellation Energy Stock Fue un Ganador el Miércoles

Why Constellation Energy Stock Was a Winner on Wednesday

The panel's discussion highlights the potential of nuclear power for AI data centers but raises significant concerns about grid interconnection …

Nasdaq · Mar 25, 2026
MRCY
▬ mixed

Venta estratégica de acciones por parte de un ejecutivo de Strategic Education por valor de $238,000 mientras que las acciones se mantienen planas este último año

Strategic Education Insider Sells $238K in Shares as Stock Holds Flat This Past Year

The panelists debated the significance of STRA's General Counsel's insider sale and the company's pivot towards EdTech. While some flagged …

Nasdaq · Mar 25, 2026
▬ mixed

La Batalla de los ETFs de Oro: ¿Es AAAU Mejor que GLD?

The Battle of the Gold ETFs: Is AAAU Better Than GLD?

The panel largely agreed that the article's data on AAAU's performance was misleading due to its shorter timeframe and backtesting …

Nasdaq · Mar 25, 2026
AMD
▬ mixed

Bolsa Hoy, 25 de Marzo: Advanced Micro Devices Sube Tras Informes de Aumento de Precios de CPU

Stock Market Today, March 25: Advanced Micro Devices Rises After Reports of CPU Price Increases

The panel is neutral on AMD's recent price hike reports, with concerns about timing of price increases, potential customer resistance, …

Nasdaq · Mar 25, 2026
IBKR
▬ mixed

Por qué las acciones de Interactive Brokers subieron casi un 4% hoy

Why Interactive Brokers Stock Bumped Nearly 4% Higher Today

Interactive Brokers' crypto transfer feature is a strategic move to attract active traders and boost platform stickiness, but it's an …

Nasdaq · Mar 25, 2026
▬ mixed

Valero se ha visto obligado a cerrar una refinería de Texas tras una explosión. Esto es lo que los inversores deben saber.

Valero Has Been Forced to Shut Down a Texas Refinery After an Explosion. Here's What Investors Need to Know.

The panel consensus is that Valero's Port Arthur refinery shutdown, due to a hydrotreater explosion, poses a significant operational risk …

Nasdaq · Mar 25, 2026
MU
▬ mixed

Las ganancias de Micron Technology se dispararon un 771% el último trimestre. Esta es una razón clave por la cual su crecimiento fue tan increíble.

Micron Technology's Earnings Skyrocketed 771% Last Quarter. This Is a Key Reason Why Its Growth Was So Incredible

The panel consensus is that the article's numbers are fabricated and do not reflect Micron's actual Q2 FY25 results. The …

Nasdaq · Mar 25, 2026
MSFT
▼ bear…

2 Acciones de IA que han bajado un 20% o más que son oportunidades de compra evidentes

2 AI Stocks Down 20% or More That Are Screaming Buys

The panel generally agrees that the current pullbacks in MSFT and META are not buying opportunities due to high valuations, …

Nasdaq · Mar 25, 2026
JBLU
▼ bear…

Bolsa Hoy, 25 de Marzo: Las Acciones de JetBlue Airways se Disparan Tras Informes de Revisión Estratégica Incluyendo Posible Venta

Stock Market Today, March 25: JetBlue Airways Stock Surges After Reports of Strategic Review Including Possible Sale

The panel is bearish on JetBlue (JBLU) due to its high debt, low margins, and regulatory hurdles, with the DOJ's …

Nasdaq · Mar 25, 2026
III
▬ mixed

International Seaways Insider Vende Acciones por $1.5 Millones -- ¿Señal o Ruido?

International Seaways Insider Sells $1.5 Million in Shares -- Signal or Noise?

The panel is divided on the interpretation of CAO James Small's sale of 35.5% of his direct holdings in INSW. …

Nasdaq · Mar 25, 2026
▬ mixed

Jefferies Financial Group Inc. Ganancias Avanzan En El Primer Trimestre

Jefferies Financial Group Inc. Profit Advances In Q1

Jefferies' Q1 results show strong revenue growth (16.1%) and EPS expansion (22.8%), but lack of segment detail and potential one-time …

Nasdaq · Mar 25, 2026
CORT
▬ mixed

Por qué los inversores le pusieron un cohete a las acciones de Corcept Therapeutics el miércoles

Why Investors Strapped a Rocket to Corcept Therapeutics Stock on Wednesday

The panel discusses Corcept Therapeutics' (CORT) FDA approval of Lifyorli, with opinions ranging from neutral to bullish. Key points include …

Nasdaq · Mar 25, 2026